Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06629311

Platelet and Autotransfusion Device in Cardiac Surgery

Study of Platelet Count Changes During the Use of Autotransfusion Device in Cardiac Surgery

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cardiac surgery is a bleeding-risk surgery and frequently requires blood transfusion. Intraoperative autotransfusion devices are used to aspirate, process and retransfuse patients' blood. These devices are effective in recovering red blood cells and limiting the need for transfusion of packed red blood cells. Some devices, such as I-SEP's SAME®, can also be used to recover platelets, but their effectiveness has not yet been evaluated in real-life situations. The aim of this study is therefore to investigate the evolution of platelet counts following the use of an intraoperative recovery device in adult patients undergoing standard cardiac surgery

Conditions

Interventions

TypeNameDescription
DEVICEAutotransfusion deviceStandard cardiac surgery using I-SEP and SAME™ autotransfusion device

Timeline

Start date
2025-02-04
Primary completion
2026-09-08
Completion
2026-09-08
First posted
2024-10-08
Last updated
2025-04-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06629311. Inclusion in this directory is not an endorsement.